ArticleBMC geriatrics2025
Prevalence and predictors of tobacco use among older people in Eastern Nepal: a community-based study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe tobacco epidemic remains a major global public health threat, responsible for more than 8 million deaths annually, including 1.2 million attributable to secondhand smoke. Smokers face nearly twice the risk of dying from cancer compared to nonsmokers, whereas quitting tobacco use reduces cancer risk at any age. In South Asia, including Nepal, tobacco consumption remains widespread due to cultural acceptance, easy availability, and weak enforcement of control measures. Against this backdrop, the present study aimed to determine the prevalence and predictors of tobacco use among older adults in Eastern Nepal.
methodsA community-based cross-sectional study was conducted among 400 elderly individuals, selected through multistage cluster sampling from four wards of Biratnagar Metropolitan City, located in Eastern Nepal. Data were collected via face-to-face interviews using a structured questionnaire. Descriptive statistics (mean, median, and standard deviation) were used to summarize the data, while inferential statistics (chi-square test) assessed associations between tobacco use and sociodemographic variables. Variables with a p-value ≤ 0.1 in the bivariate analysis were included in the multivariable logistic regression model. A backward elimination strategy was applied to derive the final model, and statistical significance was set at p < 0.05.
resultsThe prevalence of tobacco use among older people was 61% (95% CI = 56.2%-65.8%), of which 51.5% were smokeless tobacco users and 35.8% were tobacco smokers. Significant predictors of tobacco uses were observed among older age groups (age >80 years), male (OR = 5.80; 95%CI = 3.29-10.22); those with lower education levels (for illiterate OR = 2.15;95% CI = 1.41-4.45), people influenced by advertisement about tobacco (OR = 5.06; 95% CI = 3.82-10.11) and people who exposed to media (OR = 1.87; 95% CI = 1.00-3.50).
conclusionThis study demonstrates a high prevalence of tobacco use among older adults in Eastern Nepal. Factors contributing to the high prevalence of tobacco smoking include older age, male gender, illiterate population, exposure to tobacco advertising, and media exposure. These findings highlight tobacco use as a significant public health concern among older populations, who are often overlooked in tobacco control strategies. Hence, targeted interventions are urgently needed to reduce tobacco consumption in this vulnerable group, including community-based awareness programs, stricter regulation of tobacco advertising, and age-appropriate cessation support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.